Erlotad 150mg Tablet

Erlotad 150mg Tablet contains erlotinib, an anticancer medicine that acts as a tyrosine kinase receptor inhibitor. It is indicated in the treatment of non-small cell lung cancer (NSCLC), an advanced and metastatic form of lung cancer. When used alongside gemcitabine, a chemotherapeutic agent, it is also indicated for pancreatic cancer treatment. The medicine works by blocking epidermal growth factor receptors (EGFR), a protein that drives cancer cell growth. Patients whose cancer demonstrates specific EGFR gene mutations may respond to treatment with this medicine based on genetic testing results.

Before commencing treatment, inform your doctor if you are taking any stomach acid-lowering medicines, as these may reduce the effectiveness of erlotinib. Disclose to your physician any existing kidney or lung-related conditions. Provide a complete list of all medicines you are currently taking prior to starting treatment with this medication.

Report the following symptoms to your physician: difficulty breathing accompanied by cough or fever, chest pain, fever, weakness, or seizures.

To treat non-small cell lung cancer (NSCLC).

Erlotad 150 mg works by inhibiting the epidermal growth factor receptor (EGFR), a protein responsible for cancer growth.

Erlotad 150 mg tablet should be taken orally as directed by your physician or pharmacist. It should be taken on an empty stomach at least 1 hour before food or 2 hours after food. Pregnant women should avoid this medicine as it may affect the growth of the child.

Like all medications, Erlotad 150 mg tablet can cause side effects, although not everyone who takes it will experience them. Common: Diarrhea (severe) Tingling, pain, numbness and burning sensation in the hands, arms, feet or legs Hoarseness or cough Lower back or side pain Pain or difficulty in urination Rash (severe) Loss of appetite and may lose weight Difficulty in breathing Eye problems Numbness or weakness in arms and legs Rare: Chest pain or discomfort Dehydration Slurred speech Seizures Black or bloody stools Inability to speak Constipation Blurred or change in vision Stomach pain or discomfort Unusual hair loss The skin may develop darker patches Depression

Erlotad 150 mg tablets have serious effects on pregnant women as they can affect the growth of the baby in the womb, so if you are pregnant or planning for pregnancy, consult your doctor. Avoid grapefruit or grape juice as it may increase the side effects of this medicine. It should be taken on an empty stomach at least 1 hour before food or 2 hours after food.